Excitus Medical participated in Innovasjonstalen 2026 in Bodø — one of Norway’s leading arenas for innovation, preparedness, and future industry development.

Excitus Medical recently participated as an exhibitor at SOMA 2026 in the U.S — one of the leading international events for military and tactical medicine.

Ukraine is requesting ten thousand units of a Norwegian invention that its owners say has already saved lives on the front line. This could mean improved survival prospects for Ukrainian soldiers at the front and around 20 new jobs in Tromsø.

Evacuating wounded soldiers on the front lines in Ukraine is becoming increasingly difficult. CARY could help ensure that more survive.

Excitus Medical recently joined the USA–Norway Business Summit in Minneapolis, an event marking 200 years of Norwegian emigration to the United States. Organized by Innovation Norway together with Norway Health Tech and the official Norwegian defense industry delegation, the summit featured a visit to Mayo Clinic, insightful discussions on medical technology, and an audience with His Royal Highness Crown Prince Haakon, highlighting the importance of strengthening transatlantic ties. Excitus Medical showcased its groundbreaking suction device, CARY, to U.S. military and emergency services, receiving strong interest and paving the way for future collaborations and testing.

To ensure that CARY meets the highest standards under demanding conditions, we have conducted extensive field testing across Ukraine over the past year. Here, the product meets reality – and the results and feedback we have received have provided invaluable knowledge and experience. We are more confident than ever that there is a significant and urgent need for CARY.

After nearly a decade of development, testing, and collaboration, we are proud to announce a major milestone for Excitus Medical. Following a highly successful showcase at the Air Medical Transport Conference (AMTC) in Salt Lake City, CARY – our next-generation portable suction unit – is preparing to enter test trials with two leading U.S. Healthcare providers in 2025. This milestone marks the start of an exciting new chapter for our technology, our team, and the future of emergency care.